Real-world comprehensive genomic and immune profiling reveals distinct age- and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer
IntroductionYounger patients with non-small cell lung cancer (NSCLC) (
Zachary D. Wallen IntroductionYounger patients with non-small cell lung cancer (NSCLC) (